Global Electrophysiology
Ablation Market: Overview
The global electrophysiology ablation market is projected to witness
an upsurge in demand with increasing prevalence of atrial fibrillation (AF) and
arrhythmia. According to estimates, 33 million individuals across the globe
suffer from atrial fibrillation. The prevalence of this condition is projected
to increase with the aging population. In this condition, regular heart
function gets disrupted by abnormal beats. Random electrical signals pass
through, intensifying the irregular rhythm. The most effective treatment for
this condition is ablation, and the rising numbers of AF cases are likely to
augment demand in the global electrophysiology ablation market.
Electrophysiology ablation has gained wide acceptance as the
first line of treatment in case of heart rhythm management conditions,
including all kinds of arrhythmias. Electrophysiology ablation has lower risks
and creates lesser side effects on the patient. The electrophysiology ablation
market is thus poised to grow with greater benefits and optimum results offered
by the treatment.
This report gives exhaustive analysis of the global
electrophysiology ablation market, focusing on market opportunities and
possible constraints, along with the latest trends driving the market.
Request for Analysis of COVID19
Impact on Electrophysiology Ablation Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=65336
Global Electrophysiology
Ablation Market: Notable Developments
The global electrophysiology ablation market is prognosticated
to experience high sales in the coming years, on account of several factors.
The market is currently progressing at a rapid pace is several leading
development are expected to fuel market growth. Some of the key developments
impacting the global electrophysiology ablation market include:
·
Established vendors in the global electrophysiology ablation
market are offering novel products in order to gain momentum in the industry. A
key development is the soaring sales of Boston Scientific Corporations
Rhythmmia Mapping System, related disposables, and Rhythmia HDx. The company is
also working on expanding its product portfolio of navigation enabled
therapeutic devices. Such product innovations are likely to spur the global electrophysiology
ablation market to a large extent.
·
Recently, Biosense Webster Inc., received an approval for the
use of tag index guided software from the U.S. Food and Drug Administration
(FDA). Visitag Surpoint Exteral Processing Unit, the software, will be used
during catheter ablation to calculate tag index. The use of this index will
enable the standardization of workflows to achieve isolation of the pulmonary
vein. The adoption of such technologically advanced procedures is expected to
create waves in the global electrophysiology ablation market in the coming
years.
Key players operating in the global electrophysiology ablation
market include Boston Scientific Corporation, GE Healthcare, Biosense Webster
Inc., St. Jude Medical, Inc., and Medtronic plc.
Global Electrophysiology
Ablation Market Dynamics
A key factor fueling the global electrophysiology ablation
market is the rising preference for minimally invasive procedures. The growing
aged population, the rising disposable incomes of people leading to increased
spending on healthcare, and the surge in awareness regarding the comfort and
benefits of minimally invasive techniques bolster market growth. Catheter
ablation is likely to be favored by the patients, making it a leading segment
in the foreseeable future. The process has a high success rate with low risk
factors.
The vast and ever growing prevalence of cardiovascular ailments
is expected to play a key role in propelling the global electrophysiology
ablation market in the coming years. The increased number of cardiac ailments
is likely to lead to higher occurrence of heart rhythm issues, boosting
electrophysiology ablation market sales.
Pre-book Electrophysiology
Ablation Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=65336<ype=S
Unmet Medical Needs to Boost
Opportunity in Asia Pacific
North America is expected to account for a leading share in the
global electrophysiology ablation market. This could be due to high
adoption rate of advanced ablation devices in the region, along with large pool
of patients diagnosed with AF.
However, Asia Pacific electrophysiology ablation market is
likely to witness brisk growth in the coming years, ascribed to potential
opportunities in the region. Due to largely unmet medical needs and growing
awareness regarding quality of life, vendors are expected to cash in on this
regional market.
More Trending
Reports by Transparency Market Research:
